Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
Holding SBFM?
Track your performance easily

Sunshine Biopharma (SBFM) Financial Statements

330 Followers

Sunshine Biopharma Financial Overview

Sunshine Biopharma's market cap is currently ―. The company's EPS TTM is $-205.36; its P/E ratio is -0.01; Sunshine Biopharma is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-535.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 9.30M$ 7.54M$ 7.68M$ 5.96M$ 5.56M
Gross Profit$ 2.36M$ 2.35M$ 2.57M$ 1.99M$ 1.95M
EBIT$ -837.75K$ -1.21M$ -999.65K$ -572.00K$ -786.84K
EBITDA$ -837.75K$ -1.17M$ -957.29K$ -534.80K$ -751.95K
Net Income Common Stockholders$ -494.30K$ -1.28M$ -1.25M$ -651.48K$ -902.11K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.51M$ 17.43M$ 16.29M$ 18.85M$ 19.73M
Total Assets$ 29.30M$ 31.90M$ 27.35M$ 27.65M$ 28.41M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -11.51M$ -17.43M$ -16.29M$ -18.85M$ -19.73M
Total Liabilities$ 5.81M$ 7.08M$ 6.14M$ 5.69M$ 5.30M
Stockholders Equity$ 23.49M$ 24.82M$ 21.21M$ 21.96M$ 23.11M
Cash Flow-
Free Cash Flow-$ -3.85M$ -2.96M$ -438.43K$ -4.04M
Operating Cash Flow-$ -3.19M$ -2.69M$ -457.29K$ -3.78M
Investing Cash Flow-$ -668.74K$ -269.23K$ 18.86K$ -259.48K
Financing Cash Flow-$ 5.40M$ -30.52K$ -63.57K$ 4.06M
Currency in USD

Sunshine Biopharma Earnings and Revenue History

Sunshine Biopharma Debt to Assets

Sunshine Biopharma Cash Flow

Sunshine Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis